[HTML][HTML] Approved and marketed nanoparticles for disease targeting and applications in COVID-19
AAH Abdellatif, AF Alsowinea - Nanotechnology Reviews, 2021 - degruyter.com
Nano-based systems can be used to transport active medicinal products to specific parts of
the body. Most challenges with drug delivery, such as low water solubility and poor …
the body. Most challenges with drug delivery, such as low water solubility and poor …
[HTML][HTML] Nanoparticles in clinical trials: analysis of clinical trials, FDA approvals and use for COVID-19 vaccines
ED Namiot, AV Sokolov, VN Chubarev… - International journal of …, 2023 - mdpi.com
Nanoparticles are heterologous small composites that are usually between 1 and 100
nanometers in size. They are applied in many areas of medicine with one of them being …
nanometers in size. They are applied in many areas of medicine with one of them being …
[HTML][HTML] Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
F Vahedifard, K Chakravarthy - Emergent materials, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the recent
outbreak of coronavirus 2019 (COVID-19). Although nearly two decades have passed since …
outbreak of coronavirus 2019 (COVID-19). Although nearly two decades have passed since …
[HTML][HTML] An overview of the use of nanoparticles in vaccine development
Vaccines represent one of the most significant advancements in public health since they
prevented morbidity and mortality in millions of people every year. Conventionally, vaccine …
prevented morbidity and mortality in millions of people every year. Conventionally, vaccine …
Nanoparticle approaches against SARS-CoV-2 infection
Abstract Coronavirus disease 2019 (COVID-19), caused by the highly contagious severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the worst pandemic …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the worst pandemic …
The potential role of nanomedicine on COVID-19 therapeutics
RM Mainardes, C Diedrich - Therapeutic Delivery, 2020 - Taylor & Francis
Conclusion To date, there are no specific approved drugs for treating SARS-CoV-2, and
vaccines are under clinical trials. All efforts are welcome to combat the virus, and nanotech …
vaccines are under clinical trials. All efforts are welcome to combat the virus, and nanotech …
Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints
M Rai, S Bonde, A Yadav, Y Plekhanova… - Expert Review of Anti …, 2022 - Taylor & Francis
Introduction COVID-19 pandemic has been declared as a global emergency by the World
Health Organization which has mounted global pressure on the healthcare system. The …
Health Organization which has mounted global pressure on the healthcare system. The …
[PDF][PDF] Therapeutic nanoparticles: State-of-the-art of nanomedicine
Nanoparticle holds an incredible potential as an effective drug delivery system. Targeting
the delivery of drugs with narrow therapeutic indexes create a major confront for …
the delivery of drugs with narrow therapeutic indexes create a major confront for …
[HTML][HTML] Nano-biomimetic drug delivery vehicles: potential approaches for COVID-19 treatment
The current COVID-19 pandemic has tested the resolve of the global community with more
than 35 million infections worldwide and numbers increasing with no cure or vaccine …
than 35 million infections worldwide and numbers increasing with no cure or vaccine …
Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system
Continuing improvement in the pharmacological and therapeutic properties of drugs is
driving the revolution in novel drug delivery systems. In fact, a wide spectrum of therapeutic …
driving the revolution in novel drug delivery systems. In fact, a wide spectrum of therapeutic …